Antagonists of transforming growth factor-β: A novel approach to treatment of glomerulonephritis and prevention of glomerulosclerosis
- 1 March 1992
- journal article
- Published by Elsevier in Kidney International
- Vol. 41 (3), 566-570
- https://doi.org/10.1038/ki.1992.83
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Cytokines in context.The Journal of cell biology, 1991
- Proteoglycans as modulators of growth factor activitiesCell, 1991
- Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix.JCI Insight, 1990
- Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1Nature, 1990
- Negative regulation of transforming growth factor-β by the proteoglycan decorinNature, 1990
- Transforming growth factor-β regulates production of proteoglycans by mesangial cellsKidney International, 1990
- Distinguishing minimal-change disease from mesangial disordersKidney International, 1988
- Transforming growth factor β regulates the levels of different fibronectin isoforms in normal human cultured fibroblastsFEBS Letters, 1988
- New Perspectives in Cell Adhesion: RGD and IntegrinsScience, 1987
- Structural-functional relationships in diabetic nephropathy.JCI Insight, 1984